Analysis of Therapeutic Effect of Mesalazine Enteric-coated Tablet Combined with Bifidum Triple Viable Capsule in Treatment of Ulcerative Colitis  

美沙拉嗪肠溶片联合双歧三联活菌胶囊治疗溃疡性结肠炎疗效分析

作　　者：XIE Xiaodong YU Haodong 

机构地区：[1]Qianjiang Central Hospital of Chongqing, Chongqing 409000, China

出　　处：《外文科技期刊数据库(文摘版)医药卫生》2021年第12期542-544,共5页

摘　　要：Objective: to study the therapeutic effect of mesalazine enteric-coated tablet combined with bifidobacterium triple viable capsule in the treatment of ulcerative colitis. Methods: the therapeutic effect of mesalazine enteric-coated tablets combined with bifidum triple viable capsule was analyzed in 100 patients with ulcerative colitis from January 2020 to July 2021. Results: the experimental group (χ2=6.5236, P=0.0234) had higher curative effect (P < 0.05). Adverse reactions (χ2=4.5236, P=0.0011) were lower,P < 0.05. IL-6 (t=8.5241, P=0.0000) and TNF-α (t=10.2531, P=0.0000) were lower, P < 0.05. D-lactic acid (t5.2362 =,P=0.0000) and botulinum toxin (t=12.5246, P=0.0000) were lower (P < 0.05). Conclusion: mesalazine enteric-coated tablet combined with bifidum triple living capsule is effective and safe.

关 键 词：mesalazine enteric-coated tablets bifidum triple living capsule adverse reactions 

分 类 号：R725.7[医药卫生—儿科]